
STERIS plc STE
€ 180.12
-2.25%
Quartalsbericht 2026-Q3
hinzugefügt 29.05.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NYSESPB |
Anteile |
98.2 M |
Marktkapitalisierung |
$ 20.4 B |
EBITDA (LTM) |
$ 1.87 B |
P/E (LTM) |
27.74 |
P/S (LTM) |
3.59 |
EPS (LTM) |
7.67 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 67.69 | -1.36 % | $ 13.5 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 122.49 | -3.05 % | $ 7.01 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 412.02 | -3.42 % | $ 147 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 66.11 | -2.64 % | $ 40.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 139.83 | -1.53 % | $ 3.45 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.98 | -0.5 % | $ 184 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 113.94 | 0.1 % | $ 3.65 B | Nasdaq Global Select Market,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 92.34 | -4.4 % | $ 2.09 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 179.95 | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.77 | -2.75 % | $ 81 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.39 | 0.7 % | $ 32 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Merit Medical Systems
MMSI
|
$ 66.99 | -0.77 % | $ 3.96 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 9.93 | 4.31 % | $ 84.2 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.06 | -2.16 % | $ 4.04 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 78.8 | 0.11 % | $ 3.72 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 29.33 | -1.81 % | $ 1.45 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.88 | -1.66 % | $ 183 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 132.15 | -2.65 % | $ 5.9 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 68.6 | 0.78 % | $ 222 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 330.92 | -1.12 % | $ 23.9 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 24.99 | -3.03 % | $ 1.68 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.04 | -4.11 % | $ 2 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 0.31 % | $ 20.7 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 61.98 | -4.65 % | $ 204 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 26.66 | -3.23 % | $ 1.27 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.81 | -2.16 % | $ 165 M | NYSE American | ||
|
Baxter International
BAX
|
$ 20.31 | 1.4 % | $ 10.4 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 193.57 | -1.71 % | $ 28.3 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 27.51 | 0.77 % | $ 1.31 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.2 | 2.65 % | $ 275 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 12.28 | -0.49 % | $ 502 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 147.79 | -2.8 % | $ 42.5 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.2 | -1.54 % | $ 34 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.03 | -4.95 % | $ 296 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 130.76 | 0.48 % | $ 7.35 M | Nasdaq Global Select Market,SPB |